← FDA Drug Approvals (Drugs@FDA)
NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INFORLIFE · Approved 2024-04-17
Drug application
- FDA Application #
ANDA203978- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NICARDIPINE HYDROCHLORIDE IN 0.86% SODIUM CHLORIDE
- Generic name
- NICARDIPINE HYDROCHLORIDE
- Active ingredients
- NICARDIPINE HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- INFORLIFE
- Manufacturer
- WG Critical Care, LLC
- First approval
- 2024-04-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown